The amount of physical activity children and adolescents with cystic fibrosis (CF) get is linked to their age, physical…
Articles by Andrea Lobo, PhD
About one-quarter of children with cystic fibrosis (CF) who are hospitalized for pulmonary exacerbations — an acute worsening of…
Kidney failure, when the kidneys no longer work on their own, is up to 29 times more common in people…
Trikafta safely improved lung function and reduced exacerbations in people with cystic fibrosis (CF) who started treatment after…
Treatment with Alyftrek, a combination of vanzacaftor, tezacaftor, and deutivacaftor, led to better patient-reported health-related quality of life for…
An independent data monitoring committee, following a safety review, recommended that a Phase 2 trial of BX004, Biomx’s experimental…
The U.S. Food and Drug Administration (FDA) has cleared the start of the third part of a Phase 2 clinical…
Researchers have identified three groups of symptoms with interconnected severity — respiratory-energy, mood-gastrointestinal irritability, and pain-gastrointestinal abnormal motility — in…
All eligible cystic fibrosis (CF) patients in England can now receive Vertex Pharmaceuticals’ CF treatment Alyftrek (vanzacaftor/tezacaftor/deutivacaftor), after…
More than a third of caregivers of children with cystic fibrosis (CF) reported delays in getting information about the…